Kardigan, Inc (KARD)
NGM · Common
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for KARD and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
Business: Kardigan, Inc is a clinical-stage precision therapeutics company developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. The Company has curated a diverse pipeline with three late-stage clinical programs, and each is designed to move beyond symptom management and aims to redefine treatment approaches.

Company Contact

CEO
Tassos Gianakakos
CFO
Brianne Puglisi
Headquarters
131 Oyster Point Blvd., Second Floor, South San Francisco, CA 94080
Phone
415-573-3220
Investor Relations
Clayton Robertson · investors@kardigan.bio
Email Form
Contact Form »
SEC EDGAR Filings
View filings »